Clinical Trial Update: Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating conversion to roxadustat in hemodialysis patients already on stable ESA or as initial anemia treatment; completed with posted results i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia Associated With End Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-07-26